“Can We Declare Victory and Move On?” the Case Against Funding Burden-Of-Disease Studies

PharmacoEconomics - United Kingdom
doi 10.1007/s40273-014-0200-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Can We DECLARE a Victory Against Cardio-Renal Disease in Diabetes?

Cell Metabolism
Cell BiologyMolecular BiologyPhysiology
2018English

Nutrition Status and Chronic Obstructive Pulmonary Disease: Can We Move Beyond the Body Mass Index?

Nutrition in Clinical Practice
MedicineNutritionDietetics
2019English

Multiprofessional Guidelines: Can We Move Beyond Tribal Boundaries?

Quality and Safety in Health Care
1997English

More on the Bristol Affair: What Went Wrong and How Can We Move Forward?

BMJ
1999English

Limited Alignment of Publicly Competitive Disease Funding With Disease Burden in Japan

PLoS ONE
Multidisciplinary
2020English

A Call for Cease-Fire: We Can Only Move Forward Together

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2019English

Can We Vaccinate Against Type 1 Diabetes?

F1000 Biology Reports
2012English

3. The Ethics of Emergent Creativity: Can We Move Beyond Writing as Human Enterprise, Commodity and Innovation?

2019English

Wheat Blast Disease: Danger on the Move

Tropical Plant Pathology
Plant ScienceAgronomyCrop Science
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy